C. Coiffier

Polylactide-Based Reactive Micelles as a Robust Platform for mRNA Delivery

C. Lacroix, D. Gigmes, B. Verrier, 2020, Pharmaceutical Research.

A Polylactide-Based Micellar Adjuvant Improves the Intensity and Quality of Immune Response

C. Lacroix, B. Verrier, T. Trimaille, 2022, Pharmaceutics.

Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus.

B. Verrier, D. Durantel, R. Terreux, 2022, Antiviral research.

Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection

B. Verrier, V. Contreras, D. Busse, 2019, Front. Immunol..

Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection.

A. Giraud, B. Verrier, Y. Ataman-Onal, 1999, AIDS research and human retroviruses.

DLin-MC3-Containing mRNA Lipid Nanoparticles Induce an Antibody Th2-Biased Immune Response Polarization in a Delivery Route-Dependent Manner in Mice

B. Verrier, C. Monge, J. Exposito, 2023, Pharmaceutics.

Poloxamers Have Vaccine-Adjuvant Properties by Increasing Dissemination of Particulate Antigen at Distant Lymph Nodes

B. Verrier, C. Monge, E. Colomb, 2023, Molecules.